SEC 13F Intelligence

Enavate Sciences GP, LLC / CAMP

Enavate Sciences GP, LLC’s Camp4 Therapeutics Corp Position

Does Enavate Sciences GP, LLC own Camp4 Therapeutics Corp (CAMP)? Yes — 2.19M shares worth $10M (+2.75% of its 13F portfolio) as of Q1 2026, down from 3.04M shares the prior filed quarter.

Position Value
$10M
Q1 2026
Shares
2.19M
% of Portfolio
+2.75%
Quarters Held
6
currently held

Position History CAMP

Reported value by quarter
Q4 ’24: $20MQ4 ’24Q1 ’25: $15MQ1 ’25Q2 ’25: $5MQ2 ’25Q3 ’25: $11MQ3 ’25Q4 ’25: $19MQ4 ’25Q1 ’26: $10MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.19M$10M+2.75%
Q4 20253.04M$19M+3.67%
Q3 20253.79M$11M+3.47%
Q2 20253.79M$5M+3.11%
Q1 20253.79M$15M+11.41%
Q4 20243.79M$20M+14.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enavate Sciences GP, LLC’s full portfolio or all institutional holders of CAMP.